Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
Dirk Rades(University Hospital Schleswig-Holstein), Steven E. Schild(Mayo Clinic Hospital), Theo Veninga(Instituut Verbeeten), Lukas J.A. Stalpers, Volker Rudat(Saad Specialist Hospital), Rainer Schulte(Mount Vernon Hospital), Maarten C.C.M. Hulshof(Academic Medical Center), Rudolf Schwarz(Universität Hamburg), Peter Hoskin(University of Manchester), Amira Bajrovic(Mount Vernon Hospital), Philip Poortmans(University of Antwerp)
Cited by 347
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k